 CAMBRIDGE, Mass., Jan. 04, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. NASDAQ: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference being held from January 11 14, 2021. A webcast of the on-demand presentation will be available on the investor section of the Genocea website at beginning on Monday, January 11, 2021. 